{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T02:35:38Z","timestamp":1726454138771},"reference-count":44,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,4,10]],"date-time":"2006-04-10T00:00:00Z","timestamp":1144627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>When Joe Burchenal started studying medicine at the University of Pennsylvania in 1934, antibiotics had not been discovered and the survival of patients diagnosed with acute leukaemia was &lt;4\u2003months. By the time he retired in 1983, 58% of children with acute lymphoblastic leukaemia survived 5\u2003years with the majority being cured of their disease. His early work in infectious diseases and antimicrobials equipped him well, both clinically and scientifically. The approach to developing antibiotics to conquer previously incurable infection was an inspiration and model for his pioneering work when searching for drugs with activity against cancer. Trials of sequential and then combination chemotherapy followed. Success in treating lymphoid malignancies in children led him to develop treatment regimens for other more resistant cancers, and as an advocate of collaborative working he introduced multimodal therapy to tackle bulky or metastatic cancers, replacing inevitable relapse with a chance of true cure.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2006.06072.x","type":"journal-article","created":{"date-parts":[[2006,4,23]],"date-time":"2006-04-23T15:41:58Z","timestamp":1145806918000},"page":"493-503","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Joe Burchenal and the birth of combination chemotherapy"],"prefix":"10.1111","volume":"133","author":[{"given":"Angela","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.102.2644.227"},{"key":"e_1_2_3_3_1","first-page":"676","article-title":"Letter to the Editor","volume":"11","author":"Bisel H.F.","year":"1956","journal-title":"Blood"},{"key":"e_1_2_3_4_1","first-page":"820","article-title":"Cyclic chemotherapy for acute leukemia in children","volume":"22","author":"Brubaker C.A.","year":"1963","journal-title":"Blood"},{"key":"e_1_2_3_5_1","first-page":"149","article-title":"Investigations in leukaemia","volume":"3","author":"Burchenal J.H.","year":"1960","journal-title":"National Cancer Institute Monograph"},{"key":"e_1_2_3_6_1","volume-title":"Leukaemia Research Fund: 2nd Annual Guest Lecture. Approaches to the Aetiology and Treatment of Acute Leukaemia","author":"Burchenal J.H.","year":"1964"},{"key":"e_1_2_3_7_1","first-page":"2393","article-title":"Geographic chemotherapy \u2013 Burkitt's lymphoma as a stalking horse for leukaemia","volume":"26","author":"Burchenal J.H.","year":"1966","journal-title":"Cancer Research"},{"key":"e_1_2_3_8_1","first-page":"135","article-title":"The historical development of cancer chemotherapy","volume":"4","author":"Burchenal J.H.","year":"1977","journal-title":"Seminars in Oncology"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-76-18497"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-78-19069"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-78-19070"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195105)4:3<549::AID-CNCR2820040308>3.0.CO;2-J"},{"key":"e_1_2_3_13_1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.V8.11.965.965","article-title":"Clinical evaluation of a new antimetabolite, 6\u2010marcaptopurine, in the treatment of leukaemia and allied diseases","volume":"3","author":"Burchenal J.H.","year":"1953","journal-title":"Blood"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1954.tb40024.x"},{"key":"e_1_2_3_15_1","first-page":"7","article-title":"The effect of a new antimetabolite, O\u2010diazoacetyl\u20101\u2010serine, in mouse leukaemia","volume":"1","author":"Burchenal J.H.","year":"1954","journal-title":"Proceedings of the American Association of Cancer Research"},{"key":"e_1_2_3_16_1","first-page":"86","volume-title":"Wellcome Witnesses to 20th Century Medicine","author":"Christie D.A.","year":"2003"},{"key":"e_1_2_3_17_1","first-page":"593","article-title":"6\u2010Mercaptopurine: effects in mouse Sarcoma 180 and in normal animals","volume":"13","author":"Clarke D.A.","year":"1953","journal-title":"Cancer Research"},{"key":"e_1_2_3_18_1","unstructured":"Clarke D.A. Philips F.S. Stock C.C. Elion G.B.&Hitchings G.H.(1954)Combined chemotherapy of mouse sarcoma 180 (S\u2010180) azaserine and 6\u2010mercaptopurine.American Chemistry Society Abstracts 125th meeting Kansas City KS March."},{"key":"e_1_2_3_19_1","first-page":"730","article-title":"Leukemia and neuroblastoma","volume":"8","author":"Dargeon H.","year":"1951","journal-title":"Pediatrics"},{"key":"e_1_2_3_20_1","first-page":"13","article-title":"Combination chemotherapy in the treatment of advanced Hodgkin's disease (HD)","volume":"8","author":"DeVita V.T.","year":"1967","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_3_21_1","first-page":"18","article-title":"Management of childhood lymphosarcomas and reticulum cell sarcoma with high dose methotrexate and Citrovorum factor","volume":"9","author":"Djerassi I.","year":"1968","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_3_22_1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jama.1966.03110210076025","article-title":"Chemotherapy in the treatment of leukemia and Wilms\u2019 tumour","volume":"198","author":"Farber S.","year":"1966","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.106.2764.619"},{"key":"e_1_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM194806032382301"},{"key":"e_1_2_3_25_1","first-page":"102","article-title":"Clinical trials with children in acute leukemia. Cancer Chemotherapy Reports","volume":"8","author":"Fernbach D.J.","year":"1960","journal-title":"Part 1"},{"key":"e_1_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)72741-3"},{"key":"e_1_2_3_27_1","first-page":"20","article-title":"Quadruple combination therapy (VAMP) for acute lymphoblastic leukaemia of childhood","volume":"5","author":"Freireich E.J.","year":"1964","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_3_28_1","first-page":"22","article-title":"Central nervous system radiation in children with acute lymphocytic leukaemia in remission","volume":"6","author":"George P.","year":"1965","journal-title":"Proceedings of the American Association for Cancer Research"},{"key":"e_1_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(68)80217-3"},{"key":"e_1_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1946.02870380008004"},{"key":"e_1_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1955.tb05483.x"},{"key":"e_1_2_3_32_1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.V15.3.350.350","article-title":"The comparison of 6\u2010mercaptopurine with the combination of 6\u2010mercaptopurine and azaserine in the treatment of acute leukaemia in children: results of a cooperative study","volume":"15","author":"Heyn R.M.","year":"1960","journal-title":"Blood"},{"key":"e_1_2_3_33_1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jama.1967.03130220070012","article-title":"L\u2010asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia","volume":"202","author":"Hill J.M.","year":"1967","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_3_34_1","first-page":"1390","article-title":"The vinca alkaloids: a new class of oncolytic agents","volume":"23","author":"Johnson I.S.","year":"1963","journal-title":"Cancer Research"},{"key":"e_1_2_3_35_1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-5347(17)66084-1","article-title":"Wilms\u2019 tumor: a report of 45 cases and an anlysis of 1351 cases reported in the world literature from 1940 to 1958","volume":"81","author":"Klapproth H.J.","year":"1959","journal-title":"Journal of Urology"},{"key":"e_1_2_3_36_1","first-page":"497","article-title":"The blood and bone marrow changes in yellow cross gas (mustard gas) poisoning. Changes produced in the bone marrow of fatal cases","volume":"40","author":"Krumbhaar E.B.","year":"1919","journal-title":"Journal of Medical Research"},{"key":"e_1_2_3_37_1","volume-title":"The cure of childhood leukemia: into the age of miracles","author":"Laszlo J.","year":"1995"},{"key":"e_1_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-55-14520"},{"key":"e_1_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1946.02870250010003"},{"key":"e_1_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195101)4:1<39::AID-CNCR2820040105>3.0.CO;2-G"},{"key":"e_1_2_3_41_1","first-page":"808","article-title":"Hematological remissions in acute leukaemia with cyclophosphamide","volume":"18","author":"Tan C.T.C.","year":"1961","journal-title":"Blood"},{"key":"e_1_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1958.00260140111016"},{"key":"e_1_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(47)90586-2"},{"key":"e_1_2_3_44_1","first-page":"74","article-title":"The relationship of p\u2010aminobenzoic acid to the mechanism of action of sulphanilamide","volume":"21","author":"Woods D.D.","year":"1940","journal-title":"British Journal of Experimental Pathology"},{"key":"e_1_2_3_45_1","first-page":"840","article-title":"Cyclic therapy and the long\u2010term survival in childhood leukemia","volume":"22","author":"Zuelzer W.W.","year":"1963","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2006.06072.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2006.06072.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:29:59Z","timestamp":1697380199000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2006.06072.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,27]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1111\/j.1365-2141.2006.06072.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06072.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,27]]},"assertion":[{"value":"2006-04-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}